Document:

EX-10.13

 Exhibit 10.13 
 ASSIGNMENT AND ASSUMPTION AGREEMENT 
 This Assignment and Assumption
Agreement (this “Assignment”), is entered into as of March 9, 2006, by and between TVAX FOUNDERS, LLC, a Missouri limited liability company, having an address of 500 West 112th Street, Kansas City, Missouri 64114
(“Assignor”), and TVAX BIOMEDICAL, LLC, a Missouri limited liability company, having a principal place of business at 500 West 112th Street, Kansas City, Missouri 64114, its successors, legal representatives and assigns (hereinafter
“Assignee”). 
 WHEREAS, on or about June 30, 1999, Gary W. Wood, University of Kansas Medical Center, an
educational institutional organized under the laws and statutes of the State of Kansas, and the University of Kansas Medical Center Research Institute, Inc., a Kansas not-for-profit corporation, entered into that certain Technology Transfer
Agreement, as amended by the parties thereto pursuant to that certain First Amendment to Technology Transfer Agreement, dated February 16, 2006 (collectively, the “KUMC Agreement”); and 

WHEREAS, on or about October 18, 2000, Gary W. Wood and Wayne State University, a not-for-profit educational institutional organized
under the laws of the State of Michigan, entered into that certain Technology Transfer Agreement, as amended by the parties thereto pursuant to that certain First Amendment to Technology Transfer Agreement, dated February 28, 2006
(collectively, the “WSU Agreement”); and 
 WHEREAS, on or about March 9, 2006, Gary W. Wood and Assignor entered
into that certain Assignment and Assumption Agreement (the “Initial Assignment”); and 
 WHEREAS, Assignor desires to
execute and deliver this Assignment to Assignee, and Assignee wishes to accept the Assignment and to assume the obligations of Assignor under the KUMC Agreement, the WSU Agreement, and the Initial Assignment. 

NOW THEREFORE, in consideration of good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
parties hereto hereby and agree as follows: 
 1. Assignment. Assignor hereby assigns, transfers and conveys to Assignee,
its successors, legal representatives, and assigns, the Assignor’s entire rights, titles and interests in the Patents and pending applications listed on Exhibit A to this Assignment, to any know-how and any other proprietary rights related
thereto, and to the inventions therein claimed and disclosed and any divisionals, continuations, continuations in part, extensions, renewals, and reissues thereof; and in and to all applications for patents that may hereafter be filed for said
inventions in any country, all patents that may be granted for said inventions in any country and all extensions, renewals and reissues thereof. 
 Assignor hereby authorizes and requests the Director of Patents and Trademarks of the United States, and any official of any other country whose duty it is to issue patents or similar legal protection on
said applications, to issue patents or similar legal protection for said invention to Assignee, the same to be held by Assignee for its own use and benefit, to the full end of the term for which said patents or similar legal protection are or may be
granted, as fully and entirely as the same would have been held and enjoyed by Assignor had this assignment not been made. 

  
 1 

 Assignor hereby further agrees, upon the request of Assignee, to execute any and all
applications for divisionals, continuations and/or continuations in part for said invention or improvements and any supplemental oath or declaration relating thereto, and any applications for the reissue or extension of any patent that may be
granted upon said applications that Assignee may deem necessary or expedient. Assignor further agrees that in the event any said application, or patent issued thereon, becomes involved in an interference, upon request of Assignee, Assignor will
cooperate to the best of his ability with Assignee in preparing the preliminary statement and giving and producing evidence in support thereof. Assignor hereby agrees to perform, upon such request, any and all affirmative acts to obtain said patents
or similar legal protection, and vest all rights therein in Assignee as fully and entirely as the same would have been held and enjoyed by Assignor if this assignment had not been made. 

Assignor hereby covenants and warrants that as of the date hereof he is the true and lawful owner of the entire, right, title and
interest in said invention, applications, and patents which may issue pursuant thereto, that he has the full right and power to convey the same, that the same are free and clear of all liens, charges and encumbrances whatsoever, and that he has not
executed and will not execute any agreement in conflict herewith. 
 2. Assumption. Assignee hereby assumes and agrees to
perform all of Assignor’s obligations, commitments, and liabilities under the KUMC Agreement, the WSU Agreement, and the Initial Assignment and shall indemnify, defend and hold Assignor harmless with respect to such liabilities or obligations.

 IN WITNESS WHEREOF, the undersigned have set their hands as of the day and year first above written. 

 

			
	 TVAX FOUNDERS, LLC

		
	by:	 	/s/ Gary W. Wood

 
			
	Printed Name:	 	Gary W. Wood

 
			
	Title:	 	Manager
	
	“Assignor”                

  

			
	 TVAX BIOMEDICAL, LLC

		
	By:	 	/s/ Gary W. Wood

 
			
	Printed Name:	 	Gary W. Wood

 
			
	Title:	 	Manager
	
	“Assignee”                

  
 2 

 ACKNOWLEDGMENT 

 

			
	STATE OF MISSOURI	  	)
		  	) ss
	COUNTY OF JACKSON	  	)

 On this 10 day of March, 2006, before me appeared Gary W. Wood, to me personally known, who being by me
duly sworn, did say that he is the Manager of TVAX FOUNDERS, LLC, a limited liability company, and said Gary W. Wood acknowledged said instrument to be the free act and deed of said limited liability company. 

IN WITNESS WHEREOF, I have hereunto set my hand and affixed my official seal the day and year last above written. 

 

	
	/s/ Avis M. Arrington
	Notary Public
	Printed Name: Avis M. Arrington

  

	
	My Commission Expires:
	
	Aug. 6, 2007

  

			
	STATE OF MISSOURI	  	)
		  	) ss
	COUNTY OF JACKSON	  	)

 On this 10 day of March, 2006, before me appeared Gary W. Wood, to me personally known, who being by me
duly sworn, did say that he is the Chief Executive Officer of TVAX BIOMEDICAL, LLC, a limited liability company, and said Gary W. Wood acknowledged said instrument to be the free act and deed of said limited liability company. 

IN WITNESS WHEREOF, I have hereunto set my hand and affixed my official seal the day and year last above written. 

 

	
	/s/ Avis M. Arrington
	Notary Public
	Printed Name: Avis M. Arrington

  

	
	My Commission Expires:
	
	Aug. 6, 2007

  
 3 

 EXHIBIT A 
 Assignment from Gary W. Wood to TVAX Founders, LLC 
 ISSUED PATENTS

  

											
	 Country
	  	Patent	 	  	Issued	 	  	 Title

	 U.S.
	  	 	6,406,699	  	  	 	06/18/2002	  	  	Composition and Method of Cancer Antigen Immunotherapy

PENDING PATENT APPLICATIONS 
  

											
	 Country
	  	Patent	 	  	Filed	 	  	 Title

	 Canada
	  	 	2,388,221	  	  	 	10/05/2000	  	  	Composition and Method of Cancer Antigen Immunotherapy
	 Europe
	  	 	00968692.4	  	  	 	10/05/2000	  	  	Composition and Method of Cancer Antigen Immunotherapy

  
 4EX-10.14

 Exhibit 10.14 
 TVAX BIOMEDICAL, INC. 
 2011 OMNIBUS EQUITY INCENTIVE PLAN

 (Adopted December 12, 2011) 

 TABLE OF CONTENTS 

 

							
	 SECTION 1
	 	INTRODUCTION	  	 	1	  
			
	 1.1
	 	Establishment	  	 	1	  
	 1.2
	 	Purpose	  	 	1	  
	 1.3
	 	Duration	  	 	1	  
	 1.4
	 	Plan Subject to Shareholder Approval	  	 	1	  
			
	 SECTION 2
	 	DEFINITIONS	  	 	1	  
			
	 2.1
	 	Definitions	  	 	1	  
		 	1933 Act	  	 	1	  
		 	1934 Act	  	 	1	  
		 	Affiliate	  	 	2	  
		 	Award	  	 	2	  
		 	Award Agreement	  	 	2	  
		 	Beneficiary	  	 	2	  
		 	Board	  	 	2	  
		 	Bonus Shares	  	 	2	  
		 	Cause	  	 	2	  
		 	Change in Control	  	 	3	  
		 	Code	  	 	5	  
		 	Committee	  	 	5	  
		 	Company	  	 	5	  
		 	Control	  	 	5	  
		 	Covered Employee	  	 	5	  
		 	Date of Grant or Grant Date	  	 	5	  
		 	Deferred Shares	  	 	5	  
		 	Disabled or Disability	  	 	5	  
		 	Effective Date	  	 	5	  
		 	Eligible Employees	  	 	5	  
		 	Employee	  	 	5	  
		 	Executive Officer	  	 	6	  
		 	Fair Market Value	  	 	6	  
		 	Freestanding SAR	  	 	6	  
		 	Holder	  	 	6	  
		 	Incentive Stock Option	  	 	6	  
		 	Nonqualified Stock Option	  	 	6	  
		 	Option	  	 	6	  
		 	Option Agreement	  	 	6	  
		 	Option Exercise Price	  	 	6	  
		 	Optionee	  	 	7	  
		 	Participant	  	 	7	  
		 	Performance Award	  	 	7	  
		 	Performance Period	  	 	7	  

  
 i 

							
		 	Performance Shares	  	 	7	  
		 	Performance Units	  	 	7	  
		 	Person	  	 	7	  
		 	Plan	  	 	7	  
		 	Restricted Stock	  	 	7	  
		 	Restricted Stock Unit	  	 	7	  
		 	Rule 16b-3	  	 	7	  
		 	SAR	  	 	7	  
		 	SAR Holder	  	 	7	  
		 	Section 16 Person	  	 	8	  
		 	Service Provider	  	 	8	  
		 	Share	  	 	8	  
		 	Stock	  	 	8	  
		 	Subsidiary	  	 	8	  
		 	Tandem SAR	  	 	8	  
		 	Vested Option	  	 	8	  
	 2.2
	 	General Interpretive Principles	  	 	8	  
			
	 SECTION 3
	 	PLAN ADMINISTRATION	  	 	9	  
			
	 3.1
	 	Composition of Committee	  	 	9	  
	 3.2
	 	Authority of Committee	  	 	9	  
	 3.3
	 	Committee Delegation	  	 	10	  
	 3.4
	 	Determination Under the Plan	  	 	10	  
			
	 SECTION 4
	 	STOCK SUBJECT TO THE PLAN	  	 	10	  
			
	 4.1
	 	Number of Shares	  	 	10	  
	 4.2
	 	Unused and Forfeited Stock	  	 	11	  
	 4.3
	 	Adjustments in Authorized Shares	  	 	11	  
	 4.4
	 	General Adjustment Rules	  	 	12	  
			
	 SECTION 5
	 	PARTICIPATION	  	 	12	  
			
	 5.1
	 	Basis of Grant	  	 	12	  
	 5.2
	 	Types of Grants; Limits	  	 	12	  
	 5.3
	 	Award Agreements	  	 	12	  
	 5.4
	 	Restrictive Covenants	  	 	12	  
	 5.5
	 	Maximum Annual Award	  	 	13	  
			
	 SECTION 6
	 	STOCK OPTIONS	  	 	13	  
			
	 6.1
	 	Grant of Options	  	 	13	  
	 6.2
	 	Option Agreements	  	 	13	  
		 	(a) Number of Shares	  	 	13	  
		 	(b) Price	  	 	14	  

  
 ii 

							
		 	(c) Duration of Options	  	 	14	  
		 	(d) Termination of Service, Death, Disability, etc.	  	 	14	  
		 	(e) Transferability	  	 	15	  
		 	(f) Exercise, Payments, etc.	  	 	15	  
		 	(g) Date of Grant	  	 	16	  
		 	(h) Withholding	  	 	16	  
		 	(i) Adjustment of Options	  	 	17	  
	 6.3
	 	Shareholder Privileges	  	 	17	  
			
	 SECTION 7
	 	STOCK APPRECIATION RIGHTS	  	 	17	  
			
	 7.1
	 	Grant of SARs	  	 	17	  
		 	(a) Number of Shares	  	 	18	  
		 	(b) Exercise Price and Other Terms	  	 	18	  
	 7.2
	 	SAR Award Agreement	  	 	18	  
	 7.3
	 	Exercise of Tandem SARs	  	 	18	  
	 7.4
	 	Exercise of Freestanding SARs	  	 	18	  
	 7.5
	 	Expiration of SARs	  	 	18	  
	 7.6
	 	Payment of SAR Amount	  	 	19	  
			
	 SECTION 8
	 	AWARDS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS	  	 	19	  
			
	 8.1
	 	Restricted Stock Awards Granted by Committee	  	 	19	  
	 8.2
	 	Restricted Stock Unit Awards Granted by Committee	  	 	19	  
	 8.3
	 	Restrictions	  	 	19	  
	 8.4
	 	Privileges of a Shareholder, Transferability	  	 	19	  
	 8.5
	 	Enforcement of Restrictions	  	 	20	  
	 8.6
	 	Termination of Service, Death, Disability, etc.	  	 	20	  
			
	 SECTION 9
	 	PERFORMANCE SHARES, PERFORMANCE UNITS, BONUS SHARES AND DEFERRED SHARES	  	 	20	  
			
	 9.1
	 	Awards Granted by Committee	  	 	20	  
	 9.2
	 	Terms of Performance Shares or Performance Units	  	 	21	  
	 9.3
	 	Bonus Shares	  	 	21	  
	 9.4
	 	Deferred Shares	  	 	21	  
			
	 SECTION 10
	 	PERFORMANCE AWARDS; SECTION 162(M) PROVISIONS	  	 	21	  
			
	 10.1
	 	Terms of Performance Awards	  	 	21	  
	 10.2
	 	Performance Goals	  	 	22	  
	 10.3
	 	Adjustments	  	 	23	  
	 10.4
	 	Other Restrictions	  	 	23	  
	 10.5
	 	Section 162(m) Limitations	  	 	23	  
			
	 SECTION 11
	 	REORGANIZATION, CHANGE IN CONTROL OR LIQUIDATION	  	 	24	  

  
 iii

							
	 SECTION 12
	 	RIGHTS OF EMPLOYEES; PARTICIPANTS	  	 	24	  
			
	 12.1
	 	Employment	  	 	24	  
	 12.2
	 	Nontransferability	  	 	25	  
	 12.3
	 	Permitted Transfers	  	 	25	  
			
	 SECTION 13
	 	GENERAL RESTRICTIONS	  	 	25	  
			
	 13.1
	 	Investment Representations	  	 	25	  
	 13.2
	 	Compliance with Securities Laws	  	 	26	  
	 13.3
	 	Stock Restriction Agreement	  	 	26	  
			
	 SECTION 14
	 	OTHER EMPLOYEE BENEFITS	  	 	26	  
			
	 SECTION 15
	 	PLAN AMENDMENT, MODIFICATION AND TERMINATION	  	 	26	  
			
	 15.1
	 	Amendment, Modification, and Termination	  	 	26	  
	 15.2
	 	Adjustment Upon Certain Unusual or Nonrecurring Events	  	 	27	  
	 15.3
	 	Awards Previously Granted	  	 	27	  
			
	 SECTION 16
	 	WITHHOLDING	  	 	27	  
			
	 16.1
	 	Withholding Requirement	  	 	27	  
	 16.2
	 	Withholding with Stock	  	 	27	  
			
	 SECTION 17
	 	NONEXCLUSIVITY OF THE PLAN	  	 	28	  
			
	 17.1
	 	Nonexclusivity of the Plan	  	 	28	  
			
	 SECTION 18
	 	REQUIREMENTS OF LAW	  	 	28	  
			
	 18.1
	 	Requirements of Law	  	 	28	  
	 18.2
	 	Code Section 409A	  	 	28	  
	 18.3
	 	Rule 16b-3	  	 	28	  
	 18.4
	 	Governing Law	  	 	29	  

  
 iv 

 TVAX BIOMEDICAL, INC. 

2011 OMNIBUS EQUITY INCENTIVE PLAN 
 SECTION 1 
 INTRODUCTION 

 

	1.1	Establishment. TVAX Biomedical, Inc., a corporation organized and existing under the laws of the state of Delaware (the “Company”), hereby
establishes the TVAX Biomedical, Inc. 2011 Omnibus Equity Incentive Plan (the “Plan”) for certain employees of the Company and its Affiliates, certain non-employee directors of the Company and its Affiliates, certain non-employee
advisory directors of the Company and its Affiliates, and certain consultants of the Company and its Affiliates. 

  

	1.2	Purpose. The purpose of this Plan is to allow eligible employees, non-employee directors, non-employee advisory directors and consultants of the Company and its
Affiliates and subsidiaries to acquire or increase a proprietary and vested interest in the growth and performance of the Company. The Plan also is designed to assist the Company in attracting and retaining employees, non-employee directors,
non-employee advisory directors and consultants by providing them with the opportunity to participate in the success and profitability of the Company. 

  

	1.3	Duration. The Plan shall commence on the Effective Date and shall remain in effect, subject to the right of the Board to amend or terminate the Plan at any time
pursuant to Section 15 hereof, until all Shares subject to the Plan shall have been issued, delivered, purchased or acquired according to the Plan’s provisions. Unless the Plan shall be reapproved by the shareholders of the Company and the
Board renews the continuation of the Plan, no Awards shall be issued pursuant to the Plan after the tenth (10th) anniversary of the Effective Date. 

  

	1.4	Plan Subject to Shareholder Approval. Although the Plan is effective on the Effective Date, the Plan’s continued existence is subject to the Plan being
approved by the Company’s shareholders within 12 months of the Effective Date. Any Awards granted under the Plan after the Effective Date but before the approval of the Plan by the Company’s shareholders will become null and void if the
Company’s shareholders do not approve this Plan within such 12-month period. 

 SECTION 2 

DEFINITIONS 
  

	2.1	Definitions. The following terms shall have the meanings set forth below. 

 “1933 Act” means the Securities Act of 1933. 
 “1934
Act” means the Securities Exchange Act of 1934. 

  
 1 

 “Affiliate” of the Company means any Person that directly, or indirectly
through one or more intermediaries, Controls or is Controlled by, or is under common Control with the Company. 

“Award” means a grant made under this Plan in any form, which may include but is not limited to, Stock Options,
Restricted Stock, Restricted Stock Units, Bonus Shares, Deferred Shares, Performance Shares, Stock Appreciation Rights and Performance Units. 
 “Award Agreement” means a written agreement or instrument between the Company and a Holder which evidences an Award and sets forth such applicable terms, conditions and limitations
(including treatment as a Performance Award) as the Committee establishes for the Award. 
 “Beneficiary” means
the person, persons, trust or trusts which have been designated by a Holder in his or her most recent written beneficiary designation filed with the Company to receive the benefits specified under this Plan upon the death of the Holder, or, if there
is no designated beneficiary or surviving designated beneficiary, then the Person or Persons entitled by will or the laws of descent and distribution to receive such benefits. 
 “Board” means the Board of Directors of the Company. 

“Bonus Shares” means Shares that are awarded to a Participant without cost and without restriction in recognition of past
performance (whether determined by reference to another employee benefit plan of the Company or otherwise) or as an incentive to become an employee of the Company or a Subsidiary. 

“Cause” means, unless otherwise defined in an Award Agreement: 

 

	 	(i)	Participant’s conviction of, plea of guilty to, or plea of nolo contendere to a felony or other crime that involves fraud or dishonesty; 

 

	 	(ii)	Any willful action or omission by a Participant which would constitute grounds for immediate dismissal under the employment policies of the Company by which Participant
is employed, including intoxication with alcohol or illegal drugs while on the premises of the Company, or violation of sexual harassment laws or the internal sexual harassment policy of the Company by which Participant is employed;

  

	 	(iii)	Participant’s habitual neglect of duties, including repeated absences from work without reasonable excuse; or 

 

	 	(iv)	Participant’s willful and intentional material misconduct in the performance of his duties that results in financial detriment to the Company;

  
 2 

 provided, however, that for purposes of clauses (ii), (iii) and (iv), “Cause”
shall not include any one or more of the following: bad judgment, negligence or any act or omission believed by the Participant in good faith to have been in or not opposed to the interest of the Company (without intent of the Participant to gain,
directly or indirectly, a profit to which the Participant was not legally entitled). A Participant who agrees to resign from his affiliation with the Company in lieu of being terminated for Cause may be deemed, in the sole discretion of the
Committee, to have been terminated for Cause for purposes of this Plan. 
 “Change in Control” means the first
to occur of the following events: 
  

	 	(i)	Incumbent Directors cease for any reason to constitute at least a majority of the Board. 

 

	 	(ii)	Any “person” (as defined in Section 3(a)(9) of the 1934 Act and as used in Sections 13(d)(3) and 14(d)(2) of the 1934 Act) or “group” (within
the contemplation of Section 13(d)(3) of the 1934 Act and Rule 13d-5 thereunder), excluding any “person” or “group” which is a Company 25% Shareholder on the Effective Date, is or becomes a Company 25% Shareholder, other
than pursuant to (1) a Non-Qualifying Transaction, (2) an acquisition of Company Voting Securities directly from the Company which is approved by a majority of the Incumbent Directors, or (3) an Exempt Disposition.

  

	 	(iii)	A Business Combination, other than a Non-Qualifying Transaction, is consummated. 

 

	 	(iv)	The approval by the shareholders of the Company of a plan of complete liquidation or dissolution of the Company. 

For purposes of this Change in Control definition: 
  

	 	A.	“Company Voting Securities” shall mean the outstanding shares of the Company’s capital stock eligible to vote in the election of directors of the
Company. 

  

	 	B.	“Company 25% Shareholder” shall mean any “person” or “group” which, directly or indirectly, is a “beneficial owner” (as
defined in Rule 13d-3 under the 1934 Act) or controls the voting power of 25% or more of the Company Voting Securities. 

  

	 	C.	“Business Combination” shall mean a merger, consolidation, acquisition, sale of all or substantially all of the Company’s assets or properties,
statutory share exchange or similar transaction involving the Company or any of its subsidiaries that requires the approval of the Company’s shareholders, whether for the transaction itself or the issuance or exchange of securities in the
transaction. 

  

	 	D.	“Exempt Disposition” shall mean a transfer without consideration by gift, testamentary disposition, intestate succession or inheritance, or by dividend
or distribution from an entity in liquidation or otherwise, in each case, from a “person” or a member of a “group” which is a Company 25% Shareholder. 

  
 3 

	 	E.	“Incumbent Directors” shall mean (1) the directors of the Company as of the Effective Date or (2) any director of the Company elected
subsequent to the Effective Date whose election or nomination was approved by a vote of at least two-thirds of the Incumbent Directors on the Board at the time of such approval (either by specific vote of such Incumbent Directors to approve such
director or by their approval of a proxy statement of the Company in which such person is named as a nominee for director). 

  

	 	F.	“Parent Corporation” shall mean the ultimate parent entity that directly or indirectly has beneficial ownership or voting control of a majority of the
outstanding voting securities eligible to elect directors of a Surviving Corporation. 

  

	 	G.	“Surviving Corporation” shall mean the entity resulting from a Business Combination. 

 

	 	H.	“Non-Qualifying Transaction” shall mean a Business Combination in which all of the following criteria are met: (1) more than 50% of the total
voting power of the Surviving Corporation or, if applicable, the Parent Corporation, is represented by Company Voting Securities that were outstanding immediately prior to the Business Combination (or, if applicable, is represented by voting
securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) into which the Company Voting Securities were converted pursuant to the Business Combination and held in
substantially the same proportion as the Company Voting Securities were held immediately prior to the Business Combination), (2) no “person” or “group” (other than a Company 25% Shareholder or any employee benefit plan (or
related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation) would become the beneficial owner, directly or indirectly, of 25% or more of the total voting power of the outstanding voting securities eligible to elect
directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and no Company 25% Shareholder would increase its percentage of such total voting power as a result of the transaction, and (3) at least a
majority of the members of the board of directors or similar governing body of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors
at the time of the Board’s approval of the Business Combination. 

 Notwithstanding the foregoing, a
“Change in Control” shall not be deemed to occur solely because any “person” or “group” acquires beneficial ownership or voting control of more than 25% of the Company Voting Securities as a result of any
acquisition of Company Voting Securities by the Company, but if after that acquisition by the Company the “person” or “group” becomes the beneficial owner or obtains voting control of any additional Company Voting Securities, a
Change in Control shall be deemed to occur unless otherwise excluded from the definition of “Change in Control” as set forth above. 

  
 4 

 “Code” means the Internal Revenue Code of 1986, and the rules and
regulations promulgated thereunder. 
 “Committee” means (i) the Board, or (ii) one or more committees
of the Board to whom the Board has delegated all or part of its authority under this Plan. Initially, the Committee shall be the Compensation Committee of the Board, which is delegated all of the Board’s authority under this Plan as
contemplated by clause (ii) above. 
 “Company” means TVAX Biomedical, Inc., a Delaware corporation, and
any successor thereto. 
 “Control” means the possession, directly or indirectly, of the power to direct or
cause the direction of the management and policies of a person, whether through the ownership of voting securities, by contract or otherwise. 
 “Covered Employee” means an Employee that meets the definition of “covered employee” under Section 162(m)(3) of the Code. 

“Date of Grant” or “Grant Date” means, with respect to any Award, the date as of which such Award is
granted under the Plan. 
 “Deferred Shares” means Shares that are awarded to a Participant on a deferred basis
pursuant to Section 9.4. 
 “Disabled” or “Disability” means an individual (i) is
unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve
(12) months or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving
income replacement benefits for a period of not less than three (3) months under a Company- sponsored accident and health plan. Notwithstanding the above, with respect to an Incentive Stock Option and the period of time following a separation
from service in which a Holder may exercise such Incentive Stock Option, “disabled” shall have the same meaning as defined in Code section 22(e)(3). 
 “Effective Date” means November 22, 2011. 
 “Eligible
Employees” means all Employees (including officers and directors who are also Employees) of the Company or an Affiliate upon whose judgment, initiative and efforts the Company depends, or will depend, for the successful conduct of the
Company’s business. 
 “Employee” means a common law employee of the Company or an Affiliate. 

  
 5 

 “Executive Officer” means (i) the president of the Company, any vice
president of the Company, including any vice president of the Company in charge of a principal business unit, division or function (such as sales, administration, or finance), any other officer who performs a policy making function or any other
person who performs similar policy making functions for the Company, (ii) Executive Officers (as defined in part (i) of this definition) of subsidiaries of the Company who perform policy making functions for the Company, and (iii) any
Person designated or identified by the Board as being an Executive Officer for purposes of the 1933 Act or the 1934 Act, including any Person designated or identified by the Board as being a Section 16 Person. 

“Fair Market Value” means, as of any date, the value of the Stock determined in good faith, from time to time, by the
Committee in its sole discretion, and for this purpose the Committee may adopt such formulas as in its opinion shall reflect the true fair market value of such Stock from time to time and may rely on such independent advice with respect to such fair
market value as the Committee shall deem appropriate. In the event that the Shares of the Company are traded on a national securities exchange, the Committee may determine that the Fair Market Value of the Stock shall be based upon the closing price
on the trading day of the applicable date as reported in The Wall Street Journal and consistently applied. If the securities exchange is closed on the applicable date, the closing price on the next day the securities exchange is open will be
the Fair Market Value. 
 “Freestanding SAR” means any SAR that is granted independently of any Option.

 “Holder” means a Participant, Beneficiary or Permitted Transferee who is in possession of an Award Agreement
representing an Award that (i) in the case of a Participant, has been granted to such individual, (ii) in the case of a Beneficiary, has been transferred to such person under the laws of descent and distribution, or (iii) in the case
of a Permitted Transferee, has been transferred to such person as permitted by the Committee, and, with respect to all of the above clauses (i), (ii) and (iii), such Award Agreement has not expired, been canceled or terminated. 

“Incentive Stock Option” means any Option designated as such and granted in accordance with the requirements of
Section 422 of the Code. 
 “Nonqualified Stock Option” means any Option to purchase Shares that is not an
Incentive Stock Option. 
 “Option” means a right to purchase Stock at a stated price for a specified period of
time. Such definition includes both Nonqualified Stock Options and Incentive Stock Options. 
 “Option
Agreement” or “Option Award Agreement” means a written agreement or instrument between the Company and a Holder evidencing an Option. 
 “Option Exercise Price” means the price at which Shares subject to an Option may be purchased, determined in accordance with Section 6.2(b). 

  
 6 

 “Optionee” shall have the meaning as set forth in Section 6.2. For the
avoidance of any doubt, in situations where the Option has been transferred to a Permitted Transferee or passed to a Beneficiary in accordance with the laws of descent and distribution, the Optionee will not be the same person as the Holder of the
Option. 
 “Participant” means a Service Provider of the Company designated by the Committee from time to time
during the term of the Plan to receive one or more Awards under the Plan. 
 “Performance Award” means any Award
that will be issued or granted, or become vested or payable, as the case may be, upon the achievement of certain performance goals (as described in Section 10) to a Participant pursuant to Section 10. 

“Performance Period” means the period of time as specified by the Committee during which any performance goals are to be
measured. 
 “Performance Shares” means an Award made pursuant to Section 9 which entitles a Holder to
receive Shares, their cash equivalent, or a combination thereof based on the achievement of performance targets during a Performance Period. 
 “Performance Units” means an Award made pursuant to Section 9 which entitles a Holder to receive cash, Stock or a combination thereof based on the achievement of performance goals
during a Performance Period. 
 “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of
the 1934 Act and used in Sections 13(d) and 14(d) thereof, including “group” as defined in Section 13(d) thereof. 

“Plan” means the TVAX Biomedical, Inc. 2011 Omnibus Equity Incentive Plan, as set forth in this instrument and as
hereafter amended from time to time. 
 “Restricted Stock” means Stock granted under Section 8 that is
subject those restrictions set forth therein and the Award Agreement. 
 “Restricted Stock Unit” means an Award
granted under Section 8 evidencing the Holder’s right to receive a Share (or, at the Committee’s discretion, a cash payment equal to the Fair Market Value of a Share) at some future date and that is subject those restrictions set
forth therein and the Award Agreement. 
 “Rule 16b-3” means Rule 16b-3 promulgated under the 1934 Act.

 “SAR” or “Stock Appreciation Right” means an Award, granted either alone or in connection
with an Option, that is designated as a SAR pursuant to Section 7. 
 “SAR Holder” shall have the meaning
as set forth in Section 7.2. 

  
 7 

 “Section 16 Person” means a Person who is subject to obligations under
Section 16 of the 1934 Act with respect to transactions involving equity securities of the Company. 
 “Service
Provider” means an Eligible Employee, a non-employee director of the Company and its Affiliates, a non-employee advisory director of the Company and its Affiliates, and a consultant of the Company and its Affiliates. 

“Share” means a share of Stock. 
 “Stock” means authorized and issued or unissued common stock of the Company, at such par value as may be established from time to time. 

“Subsidiary” means (i) in the case of an Incentive Stock Option a “subsidiary corporation,” whether now or
hereafter existing, as defined in section 424(f) of the Code, and (ii) in the case of any other type of Award, in addition to a subsidiary corporation as defined in clause (i), a limited liability company, partnership or other entity in which
the Company controls fifty percent (50%) or more of the voting power or equity interests. 
 “Tandem SAR”
means a SAR which is granted in connection with, or related to, an Option, and which requires forfeiture of the right to purchase an equal number of Shares under the related Option upon the exercise of such SAR; or alternatively, which requires the
cancellation of an equal amount of SARs upon the purchase of the Shares subject to the Option. 
 “Vested
Option” means any Option, or portion thereof, which is exercisable by the Holder. Vested Options remain exercisable only for that period of time as provided for under this Plan and any applicable Option Award Agreement. Once a Vested Option
is no longer exercisable after otherwise having been exercisable, the Option shall become null and void. 
  

	2.2	General Interpretive Principles. (i) Words in the singular shall include the plural and vice versa, and words of one gender shall include the other gender,
in each case, as the context requires; (ii) the terms “hereof,” “herein,” and “herewith” and words of similar import shall, unless otherwise stated, be construed to refer to this Plan and not
to any particular provision of this Plan, and references to Sections are references to the Sections of this Plan unless otherwise specified; (iii) the word “including” and words of similar import when used in this Plan shall
mean “including, without limitation,” unless otherwise specified; and (iv) any reference to any U.S. federal, state, or local act, statute or law shall be deemed to also refer to all amendments or successor provisions thereto, as well
as all rules and regulations promulgated under such act, statute or law, unless the context otherwise requires. 

  
 8 

 SECTION 3 
 PLAN ADMINISTRATION 
  

	3.1	Composition of Committee. The Plan shall be administered by the Committee. To the extent the Board considers it desirable for transactions relating to Awards to
be eligible to qualify for an exemption under Rule 16b-3, the Committee shall consist of two or more directors of the Company, all of whom qualify as “non-employee directors” within the meaning of Rule 16b-3. To the extent the Board
considers it desirable for compensation delivered pursuant to Awards to be eligible to qualify for an exemption from the limit on tax deductibility of compensation under section 162(m) of the Code, the Committee shall consist of two or more
directors of the Company, all of whom shall qualify as “outside directors” within the meaning of Code section 162(m). 

  

	3.2	Authority of Committee. Subject to the terms of the Plan and applicable law, and in addition to other express powers and authorizations conferred on the
Committee by the Plan, the Committee shall have full power and authority to: 

  

	 	(a)	select the Service Providers to whom Awards may from time to time be granted hereunder; 

 

	 	(b)	determine the type or types of Awards to be granted to eligible Service Providers; 

 

	 	(c)	determine the number of Shares to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with, Awards;

  

	 	(d)	determine the terms and conditions of any Award; 

  

	 	(e)	determine whether, and to what extent, and under what circumstances Awards may be settled or exercised in cash, Shares, other securities, other Awards or other
property; 

  

	 	(f)	determine whether, and to what extent, and under what circumstance Awards may be canceled, forfeited, or suspended and the method or methods by which Awards may be
settled, exercised, canceled, forfeited, or suspended; 

  

	 	(g)	correct any defect, supply an omission, reconcile any inconsistency and otherwise interpret and administer the Plan and any instrument or Award Agreement relating to
the Plan or any Award hereunder; 

  

	 	(h)	to grant Awards in replacement of Awards previously granted under this Plan or any other compensation plan of the Company, provided that any such replacement grant that
would be considered a repricing shall be subject to shareholder approval; 

  

	 	(i)	cause the forfeiture of any Award or recover any Shares, cash or other property attributable to an Award for violations of any Company ethics policy or pursuant to any
Company compensation clawback policy, in each case, in effect on the Effective Date or as adopted or amended thereafter; 

  
 9 

	 	(j)	with the consent of the Holder, to amend any Award Agreement at any time; provided that the consent of the Holder shall not be required for any amendment (i) that,
in the Committee’s determination, does not materially adversely affect the rights of the Holder, or (ii) which is necessary or advisable (as determined by the Committee) to carry out the purpose of the Award as a result of any new
applicable law or change in an existing applicable law, or (iii) to the extent the Award Agreement specifically permits amendment without consent; 

  

	 	(k)	modify and amend the Plan, establish, amend, suspend, or waive such rules, regulations and procedures of the Plan, and appoint such agents as it shall deem appropriate
for the proper administration of the Plan; and 

  

	 	(l)	make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan. 

 

	3.3	Committee Delegation. The Committee may delegate to any member of the Board or committee of Board members such of its powers as it deems appropriate, including
the power to sub-delegate, except that, pursuant to such delegation or sub-delegation, only a member of the Board (or a committee thereof) may grant Awards from time to time to specified categories of Service Providers in amounts and on terms to be
specified by the Board or the Committee; provided that no such grants shall be made other than by the Board or the Committee to individuals who are then Section 16 Persons or other than by the Committee to individuals who are then or are deemed
likely to become a “covered employee” within the meaning of Code Section 162(m). A majority of the members of the Committee may determine its actions and fix the time and place of its meetings. 

 

	3.4	Determination Under the Plan. Unless otherwise expressly provided in the Plan, all designations, determinations, adjustments, interpretations, and other
decisions under or with respect to the Plan, any Award or Award Agreement shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive, and binding upon all persons, including the Company, any
Participant, any Holder, and any shareholder. No member of the Committee shall be liable for any action, determination or interpretation made in good faith, and all members of the Committee shall, in addition to their rights as directors, be fully
protected by the Company with respect to any such action, determination or interpretation. 

 SECTION 4 

STOCK SUBJECT TO THE PLAN 
  

	4.1	 Number of Shares. Subject to adjustment as provided in Section 4.3 and subject to the maximum amount of Shares that may be granted to an
individual in a calendar year as set forth in Section 5.5, no more than a total of Two Million Five Hundred Thousand (2,500,000) Shares are authorized for issuance under the Plan (the “Maximum

  
 10 

	 	
Limitation”) in accordance with the provisions of the Plan and subject to such restrictions or other provisions as the Committee may from time to time deem necessary. Any Shares issued
hereunder may consist, in whole or in part, of authorized and unissued shares or treasury shares. The Shares may be divided among the various Plan components as the Committee shall determine; provided, however, the maximum number of Shares that may
be issued pursuant to Incentive Stock Options shall be the Maximum Limitation. Shares that are subject to an underlying Award and Shares that are issued pursuant to the exercise of an Award shall be applied to reduce the maximum number of Shares
remaining available for use under the Plan. The Company shall at all times during the term of the Plan and while any Awards are outstanding retain as authorized and unissued Stock, or as treasury Stock, at least the number of Shares from time to
time required under the provisions of the Plan, or otherwise assure itself of its ability to perform its obligations hereunder. 

  

	4.2	Unused and Forfeited Stock. Any Shares that are subject to an Award under this Plan that are not used because the terms and conditions of the Award are not met,
including any Shares that are subject to an Award that expires or is terminated for any reason, any Shares that are used for full or partial payment of the purchase price of Shares with respect to which an Option is exercised and any Shares retained
by the Company pursuant to Section 16.2 shall automatically become available for use under the Plan. Notwithstanding the foregoing, any Shares used for full or partial payment of the purchase price of the Shares with respect to which an Option
is exercised and any Shares retained by the Company pursuant to Section 16.2 that were originally Incentive Stock Option Shares must still be considered as having been granted for purposes of determining whether the Share limitation provided
for in Section 4.1 has been reached for purposes of Incentive Stock Option grants. 

  

	4.3	Adjustments in Authorized Shares. If, without the receipt of consideration therefore by the Company, the Company shall at any time increase or decrease the
number of its outstanding Shares or change in any way the rights and privileges of such Shares such as, but not limited to, the payment of a stock dividend or any other distribution upon such Shares payable in Stock, or through a stock split,
subdivision, consolidation, combination, reclassification or recapitalization involving the Stock, such that an adjustment is necessary in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available
under the Plan then in relation to the Stock that is affected by one or more of the above events, the numbers, rights and privileges of (i) the Shares as to which Awards may be granted under the Plan, (ii) the exercise or purchase price of
each outstanding Award, and (iii) the Shares then included in each outstanding Award granted hereunder, shall be increased, decreased or changed in like manner as if the Shares underlying the Award had been issued and outstanding, fully paid
and non assessable at the time of such occurrence. The manner in which Awards are adjusted pursuant to this Section 4.3 is to be determined by the Board or the Committee; provided that all adjustments must be determined by the Board or
Committee in good faith, and must be effectuated so as to preserve the value that any Participant has in outstanding Awards as of the time of the event giving rise to any potential dilution or enlargement of rights. 

  
 11 

	4.4	General Adjustment Rules. 

  

	 	(a)	If any adjustment or substitution provided for in this Section 4 shall result in the creation of a fractional Share under any Award, such fractional Share shall be
rounded to the nearest whole Share and fractional Shares shall not be issued. 

  

	 	(b)	In the case of any such substitution or adjustment affecting an Option (including a Nonqualified Stock Option) or a SAR such substitution or adjustments shall be made
in a manner that is in accordance with the substitution and assumption rules set forth in Treasury Regulations 1.424-1 and the applicable guidance relating to Code section 409A. 

SECTION 5 

PARTICIPATION 
  

	5.1	Basis of Grant. Participants in the Plan shall be those Service Providers who, in the judgment of the Committee, have performed, are performing, or during the
term of their incentive arrangement will perform, important services in the management, operation and development of the Company, and significantly contribute, or are expected to significantly contribute, to the achievement of long-term corporate
economic objectives. 

  

	5.2	Types of Grants; Limits. Participants may be granted from time to time one or more Awards; provided, however, that the grant of each such Award shall be
separately approved by the Committee or its designee, and receipt of one such Award shall not result in the automatic receipt of any other Award. Written notice shall be given to such Participant, specifying the terms, conditions, right and duties
related to such Award. Under no circumstance shall Incentive Stock Options be granted to (i) non-employee directors, (ii) non-employee advisory directors, (iii) consultants, or (iv) any person not permitted to receive Incentive
Stock Options under the Code. 

  

	5.3	Award Agreements. Each Participant shall enter into an Award Agreement(s) with the Company, in such form as the Committee shall determine and which is consistent
with the provisions of the Plan, specifying the applicable Award terms, conditions, rights and duties. Unless otherwise explicitly stated in the Award Agreement, Awards shall be deemed to be granted as of the date specified in the grant resolution
of the Committee, which date shall be the date of any related agreement(s) with the Participant. Unless explicitly provided for in a particular Award Agreement that the terms of the Plan are being superseded, in the event of any inconsistency
between the provisions of the Plan and any such Award Agreement(s) entered into hereunder, the provisions of the Plan shall govern. 

  

	5.4	Restrictive Covenants. The Committee may, in its sole and absolute discretion, place certain restrictive covenants in an Award Agreement requiring the
Participant to agree to refrain from certain actions. Such restrictive covenants, if contained in the Award Agreement, will be binding on the Participant. 

  
 12 

	5.5	Maximum Annual Award. The maximum number of Shares with respect to which an Award or Awards may be granted to any Participant in any one taxable year of the
Company (the “Maximum Annual Participant Award”) shall not exceed Five Hundred Thousand (500,000) Shares (subject to adjustment pursuant to Sections 4.3 and 4.4). If an Option is in tandem with a SAR, such that the exercise of
the Option or SAR with respect to a Share cancels the tandem SAR or Option right, respectively, with respect to each Share, the tandem Option and SAR rights with respect to each Share shall be counted as covering but one Share for purposes of the
Maximum Annual Participant Award. 

 SECTION 6 

STOCK OPTIONS 
  

	6.1	Grant of Options. A Participant may be granted one or more Options. The Committee in its sole discretion shall designate whether an Option is an Incentive Stock
Option or a Nonqualified Stock Option. The Committee may grant both an Incentive Stock Option and a Nonqualified Stock Option to the same Participant at the same time or at different times. Incentive Stock Options and Nonqualified Stock Options,
whether granted at the same or different times, shall be deemed to have been awarded in separate grants, shall be clearly identified, and in no event shall the exercise of one Option affect the right to exercise any other Option or affect the number
of Shares for which any other Option may be exercised. 

  

	6.2	Option Agreements. Each Option granted under the Plan shall be evidenced by a written Option Award Agreement which shall be entered into by the Company and the
Participant to whom the Option is granted (the “Optionee”), and which shall contain, or be subject to, the following terms and conditions, as well as such other terms and conditions not inconsistent therewith, as the Committee may
consider appropriate in each case. 

  

	 	(a)	Number of Shares. Each Option Award Agreement shall state that it covers a specified number of Shares, as determined by the Committee. To the extent that the
aggregate Fair Market Value of Shares with respect to which Options designated as Incentive Stock Options are exercisable for the first time by any Optionee during any calendar year exceeds $100,000 or, if different, the maximum limitation in effect
at the time of grant under section 422(d) of the Code, such Options in excess of such limit shall be treated as Nonqualified Stock Options. The foregoing shall be applied by taking Options into account in the order in which they were granted. For
the purposes of the foregoing, the Fair Market Value of any Share shall be determined as of the time the Option with respect to such Share is granted. In the event the foregoing results in a portion of an Option designated as an Incentive Stock
Option exceeding the $100,000 limitation, only such excess shall be treated as a Nonqualified Stock Option. 

  
 13 

	 	(b)	Price. Each Option Award Agreement shall state the Option Exercise Price at which each Share covered by an Option may be purchased. Such Option Exercise Price
shall be determined in each case by the Committee, but in no event shall the Option Exercise Price for each Share covered by an Option be less than the Fair Market Value of the Stock on the Option’s Grant Date, as determined by the Committee;
provided, however, that the Option Exercise Price for each Share covered by an Incentive Stock Option granted to an Eligible Employee who then owns stock possessing more than 10% of the total combined voting power of all classes of stock of the
Company or any parent or Subsidiary corporation of the Company must be at least 110% of the Fair Market Value of the Stock subject to the Incentive Stock Option on the Option’s Grant Date. 

 

	 	(c)	Duration of Options. Each Option Award Agreement shall state the period of time, determined by the Committee, within which the Option may be exercised by the
Holder (the “Option Period”). The Option Period must expire, in all cases, not more than ten years from the Option’s Grant Date; provided, however, that the Option Period of an Incentive Stock Option granted to an Eligible
Employee who then owns Stock possessing more than 10% of the total combined voting power of all classes of Stock of the Company must expire not more than five years from the Option’s Grant Date. Each Option Award Agreement also shall state the
periods of time, if any, as determined by the Committee, when incremental portions of each Option shall become exercisable. If any Option or portion thereof is not exercised during its Option Period, such unexercised portion shall be deemed to have
been forfeited and have no further force or effect. 

  

	 	(d)	Termination of Service, Death, Disability, etc. Each Option Agreement shall state the period of time, if any, determined by the Committee, within which the
Vested Option may be exercised after an Optionee ceases to be a Service Provider and may provide for different periods of time depending upon whether such cessation as a Service Provider was on account of the Participant’s death, Disability,
voluntary resignation, retirement, cessation as a director, the Company having terminated such Optionee’s employment with or without cause, or the Company having terminated such Optionee’s service as a consultant for any or no reason. In
the case of a Participant that is an Employee, a termination of service shall not occur if the Participant is on military leave, sick leave or other bona fide leave of absence (such as temporary employment by the government) if the period of such
leave does not exceed six months, or if longer, as long as the Participant’s right to reemployment with the Company or an Affiliate is provided either by statute or by contract. In the case of a Participant that is both an Employee and a
director of the Company, the Participant’s cessation as an Employee but continuation as a director of the Company will not constitute a termination of service under the Plan. Unless an Option Agreement provides otherwise, a Participant’s
change in status between serving as an employee and/or director will not be considered a termination of the Participant serving as a Service Provider for purposes of any Option expiration period under the Plan. 

  
 14 

	 	(e)	Transferability. Except as otherwise determined by the Committee, Options shall not be transferable by the Optionee except by will or pursuant to the laws of
descent and distribution. Each Vested Option shall be exercisable during the Optionee’s lifetime only by him or her, or in the event of Disability or incapacity, by his or her guardian or legal representative. Shares issuable pursuant to any
Option shall be delivered only to or for the account of the Optionee, or in the event of Disability or incapacity, to his or her guardian or legal representative. 

 

	 	(f)	Exercise, Payments, etc. 

  

	 	(i)	Unless otherwise provided in the Option Award Agreement, each Vested Option may be exercised by delivery to the Corporate Secretary of the Company a written notice
specifying the number of Shares with respect to which such Option is exercised and payment of the Option Exercise Price. Such notice shall be in a form satisfactory to the Committee or its designee and shall specify the particular Vested Option that
is being exercised and the number of Shares with respect to which the Vested Option is being exercised. The exercise of the Vested Option shall be deemed effective upon receipt of such notice by the Corporate Secretary and payment to the Company.
The purchase of such Stock shall take place at the principal offices of the Company upon delivery of such notice, at which time the purchase price of the Stock shall be paid in full by any of the methods or any combination of the methods set forth
in clause (ii) below. 

  

	 	(ii)	The Option Exercise Price may be paid by any of the following methods: 

  

	 	A.	Cash or certified bank check; 

  

	 	B.	By delivery to the Company Shares then owned by the Holder, the Fair Market Value of which equals the purchase price of the Stock purchased pursuant to the Vested
Option, properly endorsed for transfer to the Company; provided, however, that Shares used for this purpose must have been held by the Holder for such minimum period of time as may be established from time to time by the Committee; and provided
further that the Fair Market Value of any Shares delivered in payment of the purchase price upon exercise of the Options shall be the Fair Market Value as of the exercise date, which shall be the date of delivery of the Stock used as payment of the
Option Exercise Price; 

  

	 	  	In lieu of actually surrendering to the Company the Shares then owned by the Holder, the Committee may, in its discretion permit the Holder to submit to the Company a
statement affirming ownership by the Holder of such number of Shares and request that such Shares, although not actually surrendered, be deemed to have been surrendered by the Holder as payment of the exercise price; 

  
 15 

	 	C.	For any Holder other than an Executive Officer or except as otherwise prohibited by the Committee, by payment through a broker in accordance with procedures permitted
by Regulation T of the Federal Reserve Board; 

  

	 	D.	For any Nonqualified Stock Option, by a “net exercise” arrangement pursuant to which the Company will not require a payment of the Option Exercise Price but
will reduce the number of shares of common stock issued upon the exercise by the largest number of whole shares that has a fair market value on the date of exercise that does not exceed the aggregate Option Exercise Price. With respect to any
remaining balance of the aggregate option price, the Company will accept a cash payment from the Holder; or 

  

	 	E.	Any combination of the consideration provided in the foregoing subsections (A), (B), (C) and (D). 

 

	 	(iii)	The Company may not guarantee a third-party loan obtained by a Holder to pay any portion of the entire Option Exercise Price of the Shares. 

 

	 	(g)	Date of Grant. Unless otherwise specifically specified in the Option Award Agreement, an option shall be considered as having been granted on the date specified
in the grant resolution of the Committee. 

  

	 	(h)	Withholding. 

  

	 	(A)	Nonqualified Stock Options. Upon any exercise of a Nonqualified Stock Option, the Optionee shall make appropriate arrangements with the Company to provide for
the minimum amount of additional withholding required by applicable federal and state income tax and payroll laws, including payment of such taxes through delivery of Stock or by withholding Stock to be issued under the Option, as provided in
Section 16 hereof. 

  

	 	(B)	 Incentive Stock Options. In the event that an Optionee makes a disposition (as defined in Section 424(c) of the Code) of any Stock acquired
pursuant to the exercise of an Incentive Stock Option prior to the later of (i) the expiration of two years from the date on which the Incentive Stock Option was granted or (ii) the expiration of one year from the date on which the Option
was exercised, the Participant shall send written notice to the Company at its principal office (Attention: Corporate Secretary) of the date of such disposition, the number of shares disposed of, the amount of proceeds received from such
disposition, and any other information 

  
 16 

	 	
relating to such disposition as the Company may reasonably request. The Optionee shall, in the event of such a disposition, make appropriate arrangements with the Company to provide for the
amount of additional withholding, if any, required by applicable Federal and state income tax laws. 

  

	 	(i)	Adjustment of Options. Subject to the limitations set forth below and those contained in Sections 6 and 15, the Committee may make any adjustment in the Option
Exercise Price, the number of Shares subject to, or the terms of, an outstanding Option and a subsequent granting of an Option by amendment or by substitution of an outstanding Option. Such amendment, substitution, or re-grant may result in terms
and conditions (including Option Exercise Price, number of Shares covered, vesting schedule or exercise period) that differ from the terms and conditions of the original Option; provided, however, the Committee may not, without shareholder approval
(i) amend an Option to reduce its Option Exercise Price, (ii) cancel an Option and regrant an Option with a lower Option Exercise Price than the original Option Exercise Price of the cancelled Option, or (iii) take any other action
(whether in the form of an amendment, cancellation or replacement grant) that has the effect of “repricing” an Option, as defined under applicable NASDAQ Stock Market rules or the rules of the established stock exchange or quotation system
on which the Company Stock is then listed or traded if such Exchange’s or quotation system’s rules define what constitutes a repricing. Other than with respect to a modification that a reasonable person would not find to be a material
adverse change in an Optionee’s rights under an Option, the Committee also may not adversely affect the rights of any Optionee to previously granted Options without the consent of such Optionee. If such action is affected by the amendment, the
effective date of such amendment shall he the date of the original grant. Any adjustment, modification, extension or renewal of an Option shall be effected such that the Option is either exempt from, or is compliant with, Code section 409A.

  

	6.3	Shareholder Privileges. No Holder shall have any rights as a shareholder with respect to any Shares covered by an Option until the Holder becomes the holder of
record of such Stock, and no adjustments shall be made for dividends or other distributions or other rights as to which there is a record date preceding the date such Holder becomes the holder of record of such Stock, except as provided in
Section 4. 

 SECTION 7 
 STOCK APPRECIATION RIGHTS 
  

	7.1	Grant of SARs. Subject to the terms and conditions of this Plan, a SAR may be granted to a Participant at any time and from time to time as shall be determined
by the Committee in its sole discretion. The Committee may grant Freestanding SARs or Tandem SARs, or any combination thereof. 

  
 17 

	 	(a)	Number of Shares. The Committee shall have complete discretion to determine the number of SARs granted to any Participant, subject to the limitations imposed in
this Plan and by applicable law. 

  

	 	(b)	Exercise Price and Other Terms. All SARs shall be granted with an exercise price no less than the Fair Market Value of the underlying Shares on the SARs’
Date of Grant. The Committee, subject to the provisions of this Plan, shall have complete discretion to determine the terms and conditions of SARs granted under this Plan. The exercise price per Share of Tandem SARs shall equal the exercise price
per Share of the related Option. 

  

	7.2	SAR Award Agreement. Each SAR granted under the Plan shall be evidenced by a written SAR Award Agreement which shall be entered into by the Company and the
Participant to whom the SAR is granted (the “SAR Holder”), and which shall specify the exercise price per share, the terms of the SAR, the conditions of exercise, and such other terms and conditions as the Committee in its sole
discretion shall determine. 

  

	7.3	Exercise of Tandem SARs. Tandem SARs may be exercised for all or part of the Shares subject to the related Option upon the surrender of the right to exercise the
equivalent portion of the related Option. A Tandem SAR may be exercised only with respect to the Shares for which its related Option is then exercisable. With respect to a Tandem SAR granted in connection with an Incentive Stock Option: (a) the
Tandem SAR shall expire no later than the expiration of the underlying Incentive Stock Option; (b) the value of the payout with respect to the Tandem SAR shall be for no more than one hundred percent (100%) of the difference between the
Exercise Price per Share of the underlying Incentive Stock Option and the Fair Market Value per Share of the Shares subject to the underlying Incentive Stock Option at the time the Tandem SAR is exercised; and (c) the Tandem SAR shall be
exercisable only when the Fair Market Value per Share of the Shares subject to the Incentive Stock Option exceeds the per share Option Price per Share of the Incentive Stock Option. 

 

	7.4	Exercise of Freestanding SARs. Freestanding SARs shall be exercisable on such terms and conditions as the Committee in its sole discretion shall determine;
provided, however, that no Freestanding SAR granted to a Section 16 Person shall be exercisable until at least six (6) months after the Date of Grant or such shorter period as may be permissible while maintaining compliance with Rule
16b-3. 

  

	7.5	 Expiration of SARs. Each SAR Award Agreement shall state the period of time, if any, determined by the Committee, within which the SAR may be
exercised after a SAR Holder ceases to be a Service Provider and may provide for different periods of time depending upon whether such cessation as a Service Provider was on account of the Participant’s death, Disability, voluntary resignation,
cessation as a director, the Company having terminated such SAR Holder’s employment with or without Cause, or the Company having terminated such SAR Holder’s service as a consultant for any or no reason. Unless otherwise specifically
provided for in the SAR Award agreement, a Tandem SAR granted under this Plan shall be exercisable at such time or times and only 

  
 18 

	 	
to the extent that the related Option is exercisable. The Tandem SAR shall terminate and no longer be exercisable upon the termination or exercise of the related Options, except that Tandem SARs
granted with respect to less than the full number of shares covered by a related Option shall not be reduced until the exercise or termination of the related Option exceeds the number of Shares not covered by the SARs. 

 

	7.6	Payment of SAR Amount. Upon exercise of a SAR, a Holder shall be entitled to receive payment from the Company in an amount determined by multiplying (i) the
positive difference between the Fair Market Value of a Share on the date of exercise over the exercise price per Share by (ii) the number of Shares with respect to which the SAR is exercised. The payment upon a SAR exercise may be in whole
Shares of equivalent value, cash, or a combination of whole Shares and cash. Fractional Shares shall be rounded to the nearest whole Share. 

 SECTION 8 
 AWARDS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS 

 

	8.1	Restricted Stock Awards Granted by Committee. Coincident with or following designation for participation in the Plan and subject to the terms and provisions of
the Plan, the Committee, at any time and from time to time, may grant Restricted Stock to any Service Provider in such amounts as the Committee shall determine. 

 

	8.2	Restricted Stock Unit Awards Granted by Committee. Coincident with or following designation for participation in the Plan and subject to the terms and provisions
of the Plan, the Committee may grant a Service Provider Restricted Stock Units in connection with or separate from a grant of Restricted Stock. Upon the vesting of Restricted Stock Units, the Holder shall be entitled to receive the full value of the
Restricted Stock Units payable in either Shares or cash. 

  

	8.3	Restrictions. A Holder’s right to retain Shares of Restricted Stock or be paid with respect to Restricted Stock Units shall be subject to such restrictions,
including him or her continuing to perform as a Service Provider for a restriction period specified by the Committee, or the attainment of specified performance goals and objectives, as may be established by the Committee with respect to such Award.
The Committee may in its sole discretion require different periods of service or different performance goals and objectives with respect to (i) different Holders, (ii) different Restricted Stock or Restricted Stock Unit Awards, or
(iii) separate, designated portions of the Shares constituting a Restricted Stock Award. Any grant of Restricted Stock or Restricted Stock Units shall contain terms such that the Award is either exempt from Code section 409A or complies with
such section. 

  

	8.4	 Privileges of a Shareholder, Transferability. Unless otherwise provided in the Award Agreement, a Participant shall have all voting, dividend,
liquidation and other rights with respect to Shares of Restricted Stock, provided however that any dividends paid on Shares of Restricted Stock prior to such Shares becoming vested shall be held in escrow by the Company and subject to the same
restrictions on transferability and forfeitability 

  
 19 

	 	
as the underlying Shares of Restricted Stock. Any voting, dividend, liquidation or other rights shall accrue to the benefit of a Holder only with respect to Shares of Restricted Stock held by, or
for the benefit of, the Holder on the record date of any such dividend or voting date. A Participant’s right to sell, encumber or otherwise transfer such Restricted Stock shall, in addition to the restrictions otherwise provided for in the
Award Agreement, be subject to the limitations of Section 12.2 hereof. The Committee may determine that a Holder of Restricted Stock Units is entitled to receive dividend equivalent payments on such units. If the Committee determines that
Restricted Stock Units shall receive dividend equivalent payments, such feature will be specified in the applicable Award Agreement. Restricted Stock Units shall not have any voting rights. 

 

	8.5	Enforcement of Restrictions. The Committee may in its sole discretion require one or more of the following methods of enforcing the restrictions referred to in
Section 8.2 and 8.3: 

  

	 	(a)	placing a legend on the stock certificates representing Restricted Stock, or the Restricted Stock Unit Award Agreement, as applicable, referring to restrictions;

  

	 	(b)	requiring the Holder to keep the stock certificates representing Restricted Stock, duly endorsed, in the custody of the Company while the restrictions remain in effect;

  

	 	(c)	requiring that the stock certificates representing Restricted Stock, duly endorsed, be held in the custody of a third party nominee selected by the Company who will
hold such stock certificates on behalf of the Holder while the restrictions remain in effect; or 

  

	 	(d)	inserting a provision into the Restricted Stock Award Agreement prohibiting assignment of such Award Agreement until the terms and conditions or restrictions contained
therein have been satisfied or released, as applicable. 

  

	8.6	Termination of Service, Death, Disability, etc. Unless otherwise provided in an Award Agreement, in the event of the death or Disability of a Participant, all
service period and other restrictions applicable to Restricted Stock Awards then held by him or her shall lapse, and such Awards shall become fully nonforfeitable. Subject to Section 11, in the event a Participant ceases to be a Service
Provider for any other reason, any Restricted Stock Awards as to which the service period or other vesting conditions for have not been satisfied shall be forfeited. 

SECTION 9 

PERFORMANCE SHARES, PERFORMANCE UNITS, BONUS SHARES 
 AND DEFERRED SHARES 
  

	9.1	Awards Granted by Committee. Coincident with or following designation for participation in the Plan, a Participant may be granted Performance Shares or
Performance Units. 

  
 20 

	9.2	Terms of Performance Shares or Performance Units. The Committee shall establish maximum and minimum performance targets to be achieved during the applicable
Performance Period. Each grant of a Performance Share or Performance Unit Award shall be subject to additional terms and conditions not inconsistent with the provisions of the Plan. The Committee shall determine what, if any, payment is due with
respect to an Award and whether such payment shall be made in cash, Stock or some combination. 

  

	9.3	Bonus Shares. Subject to the terms of the Plan, the Committee may grant Bonus Shares to any Participant, in such amount and upon such terms and at any time and
from time to time as shall be determined by the Committee. 

  

	9.4	Deferred Shares. Subject to the terms and provisions of the Plan, Deferred Shares may be granted to any Participant in such amounts and upon such terms, and at
any time and from time to time, as shall be determined by the Committee. The Committee may impose such conditions or restrictions on any Deferred Shares as it may deem advisable, including time-vesting restrictions and deferred payment features. The
Committee may cause the Company to establish a grantor trust to hold Shares subject to Deferred Share Awards. Without limiting the generality of the foregoing, the Committee may grant to any Participant, or permit any Participant to elect to
receive, Deferred Shares in lieu of or in substitution for any other compensation (whether payable currently or on a deferred basis, and whether payable under this Plan or otherwise) which such Participant may be eligible to receive from the Company
or a Subsidiary. Any grant of Deferred Shares shall comply with Section 409A of the Code. 

 SECTION 10

 PERFORMANCE AWARDS; SECTION 162(M) PROVISIONS 
  

	10.1	Terms of Performance Awards. Except as provided in Section 11, Performance Awards will be issued or granted, or become vested or payable, only after the end
of the relevant Performance Period. The performance goals to be achieved for each Performance Period and the amount of the Award to be distributed upon satisfaction of those performance goals shall be conclusively determined by the Committee. When
the Committee determines whether a performance goal has been satisfied for any Performance Period, the Committee, where the Committee deems appropriate, may make such determination using calculations which alternatively include and exclude one, or
more than one, “extraordinary items” as determined under U.S. generally accepted accounting principles, and the Committee may determine whether a performance goal has been satisfied for any Performance Period taking into account the
alternative which the Committee deems appropriate under the circumstances. The Committee also may take into account any other unusual or non-recurring items, including the charges or costs associated with restructurings of the Company, discontinued
operations, and the cumulative effects of accounting changes and, further, may take into account any unusual or non-recurring events affecting the Company, changes in applicable tax laws or accounting principles or such other factors as the
Committee may determine reasonable and appropriate under the circumstances (including any factors that could result in the Company’s paying non-deductible compensation to an Employee, non-employee director, non-employee advisory director or
consultant). 

  
 21 

	10.2	Performance Goals. If an Award is subject to this Section 10, then the lapsing of restrictions thereon, or the vesting thereof, and the distribution of
cash, Shares or other property pursuant thereto, as applicable, shall be subject to the achievement of one or more objective performance goals established by the Committee, which shall be based on the attainment of one or any combination of the
following metrics, and which may be established on an absolute or relative basis for the Company as a whole or any of its subsidiaries, operating divisions or other operating units: 

 

	 	(a)	Earnings measures (either in the aggregate or on a per-Share basis), including or excluding one or more of interest, taxes, depreciation, amortization or similar
financial accounting measurements; 

  

	 	(b)	Operating profit (either in the aggregate or on a per-Share basis); 

  

	 	(c)	Operating income (either in the aggregate or on a per-Share basis); 

  

	 	(d)	Net earnings on either a LIFO or FIFO basis (either in the aggregate or on a per- Share basis); 

 

	 	(e)	Net income or loss (either in the aggregate or on a per-Share basis); 

  

	 	(f)	Cash flow provided by operations (either in the aggregate or on a per-Share basis); 

 

	 	(g)	Cash flow returns, including cash flow returns on invested capital (cash flow from operating activities minus capital expenditures, the difference of which is divided
by the difference between total assets and non-interest bearing current liabilities); 

  

	 	(h)	Ratio of debt to debt plus equity; 

  

	 	(i)	Net borrowing; 

  

	 	(j)	Credit quality or debt ratings; 

  

	 	(k)	Inventory levels, inventory turn or shrinkage; 

  

	 	(l)	Revenues; 

  

	 	(m)	Free cash flow (either in the aggregate or on a per-Share basis); 

  

	 	(n)	Reductions in expense levels, determined either on a Company-wide basis or with respect to any one or more business units; 

 

	 	(o)	Operating and maintenance cost management and employee productivity; 

  
 22 

	 	(p)	Gross margin; 

  

	 	(q)	Return measures (including return on assets, investment, equity, or sales); 

 

	 	(r)	Productivity increases; 

  

	 	(s)	Share price (including attainment of a specified per-Share price during the Incentive Period; growth measures and total shareholder return or attainment by the Shares
of a specified price for a specified period of time); 

  

	 	(t)	Growth or rate of growth of any of the above Business Criteria; 

  

	 	(u)	Strategic business criteria, consisting of one or more objectives based on meeting specified revenue, market share, market penetration, geographic business expansion
goals, objectively identified project milestones, production volume levels, cost targets, customer satisfaction, and goals relating to acquisitions or divestitures; 

 

	 	(v)	Achievement of business or operational goals such as market share and/or business development; and/or 

 

	 	(w)	Accomplishment of mergers, acquisitions, dispositions, public offerings, or similar extraordinary business transactions; 

provided that applicable incentive goals may be applied on a pre- or post-tax basis; and provided further that the Committee may, when the
applicable incentive goals are established, provide that the formula for such goals may include or exclude items to measure specific objectives, such as losses from discontinued operations, extraordinary gains or losses, the cumulative effect of
accounting changes, acquisitions or divestitures, foreign exchange impacts and any unusual, nonrecurring gain or loss. As established by the Committee, the incentive goals may include, without limitation, GAAP and non-GAAP financial measures.

  

	10.3	Adjustments. Notwithstanding any provision of the Plan other than Section 4.3 or Section 11, with respect to any Award that is subject to this
Section 10, the Committee may not adjust upwards the amount payable pursuant to such Award, nor may it waive the achievement of the applicable performance goals except in the case of the death or Disability of the Participant.

  

	10.4	Other Restrictions. The Committee shall have the power to impose such other restrictions on Awards subject to this Section 10 as it may deem necessary or
appropriate to insure that such Awards satisfy all requirements for “performance-based compensation” within the meaning of Code Section 162(m)(4)(B). 

 

	10.5	Section 162(m) Limitations. Notwithstanding any other provision of this Plan, if the Committee determines at the time any Award is granted to a Participant
that such Participant is, or is likely to be at the time he or she recognizes income for federal income tax purposes in connection with such Award, a Covered Employee, then the Committee may provide that this Section 10 is applicable to such
Award. 

  
 23 

 
SECTION 11 
 REORGANIZATION, CHANGE IN CONTROL OR LIQUIDATION 

Except as otherwise provided in this Plan, an Award Agreement or other agreement approved by the Committee to which any Participant is a
party, in the event that the Company undergoes a Change in Control, each Option, share of Restricted Stock and/or other Award shall without regard to any vesting schedule, restriction or performance target, automatically become fully exercisable,
fully vested or fully payable, as the case may be, as of the date of such Change in Control. In addition to the foregoing, in the event the Company undergoes a Change in Control or in the event of a corporate merger, consolidation, major acquisition
of property (or stock), separation, reorganization or liquidation in which the Company is a party and in which a Change in Control does not occur, the Committee, or the board of directors of any corporation assuming the obligations of the Company,
shall have the full power and discretion to prescribe and amend the terms and conditions for the exercise, or settlement, of any outstanding Awards granted hereunder. The Committee may remove restrictions on Restricted Stock and Restricted Stock
Units and may modify the performance requirements for any other Awards. The Committee may provide that Options or other Awards granted hereunder must be exercised in connection with the closing of such transactions, and that if not so exercised such
Awards will expire. Any such determinations by the Committee may be made generally with respect to all Participants, or may be made on a case-by-case basis with respect to particular Participants. Notwithstanding the foregoing, any transaction
undertaken for the purpose of reincorporating the Company under the laws of another jurisdiction, if such transaction does not materially affect the beneficial ownership of the Company’s capital stock, such transaction shall not constitute a
merger, consolidation, major acquisition of property for stock, separation, reorganization, liquidation, or Change in Control. 

SECTION 12 

RIGHTS OF EMPLOYEES; PARTICIPANTS 
  

	12.1	Employment. Nothing contained in the Plan or in any Award granted under the Plan shall confer upon any Participant any right with respect to the continuation of
his or her services as a Service Provider or interfere in any way with the right of the Company, subject to the terms of any separate employment or consulting agreement to the contrary, at any time to terminate such services or to increase or
decrease the compensation of the Participant from the rate in existence at the time of the grant of an Award. Whether an authorized leave of absence, or absence in military or government service, shall constitute a termination of Participant’s
services as a Service Provider shall be determined by the Committee at the time. 

  
 24 

	12.2	Nontransferability. Except as provided in Section 12.3, no right or interest of any Holder in an Award granted pursuant to the Plan shall be assignable or
transferable during the lifetime of the Participant, either voluntarily or involuntarily, or be subjected to any lien, directly or indirectly, by operation of law, or otherwise, including execution, levy, garnishment, attachment, pledge or
bankruptcy. In the event of a Participant’s death, a Holder’s rights and interests in all Awards shall, to the extent not otherwise prohibited hereunder, be transferable by testamentary will or the laws of descent and distribution, and
payment of any amounts due under the Plan shall be made to, and exercise of any Options or SARs may be made by, the Holder’s legal representatives, heirs or legatees. If, in the opinion of the Committee, a person entitled to payments or to
exercise rights with respect to the Plan is disabled from caring for his or her affairs because of a mental condition, physical condition or age, payment due such person may be made to, and such rights shall be exercised by, such person’s
guardian, conservator, or other legal personal representative upon furnishing the Committee with evidence satisfactory to the Committee of such status. “Transfers” shall not be deemed to include transfers to the Company or “cashless
exercise” procedures with third parties who provide financing for the purpose of (or who otherwise facilitate) the exercise of Awards consistent with applicable laws and the authorization of the Committee. 

 

	12.3	Permitted Transfers. Pursuant to conditions and procedures established by the Committee from time to time, the Committee may permit Awards to be transferred to,
exercised by and paid to certain persons or entities related to a Participant, including members of the Participant’s immediate family, charitable institutions, or trusts or other entities whose beneficiaries or beneficial owners are members of
the Participant’s immediate family and/or charitable institutions (a “Permitted Transferee”). In the case of initial Awards, at the request of the Participant, the Committee may permit the naming of the related person or entity
as the Award recipient. Any permitted transfer shall be subject to the condition that the Committee receive evidence satisfactory to it that the transfer is being made for estate and/or tax planning purposes on a gratuitous or donative basis and
without consideration (other than nominal consideration). Notwithstanding the foregoing, Incentive Stock Options shall only be transferable to the extent permitted in Section 422 of the Code, or such successor provision thereto, and the treasury
regulations thereunder. 

 SECTION 13 
 GENERAL RESTRICTIONS 
  

	13.1	Investment Representations. The Company may require any person to whom an Option or other Award is granted, as a condition of exercising such Option or receiving
Stock under the Award, to give written assurances in substance and form satisfactory to the Company and its counsel to the effect that such person is acquiring the Stock subject to the Option or the Award for his or her own account for investment
and not with any present intention of selling or otherwise distributing the same, and to such other effects as the Company deems necessary or appropriate in order to comply with federal and applicable state securities laws. Legends evidencing such
restrictions may be placed on the certificates evidencing the Stock. 

  
 25 

	13.2	Compliance with Securities Laws. 

  

	 	(a)	Each Award shall be subject to the requirement that, if at any time counsel to the Company shall determine that the listing, registration or qualification of the Shares
subject to such Award upon any securities exchange or under any state or federal law, or the consent or approval of any governmental or regulatory body, is necessary as a condition of, or in connection with, the issuance or purchase of Shares
thereunder, such Award may not be accepted or exercised in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained on conditions acceptable to the Committee. Nothing herein shall be
deemed to require the Company to apply for or to obtain such listing, registration or qualification. 

  

	 	(b)	Each Holder who is a director or an Executive Officer is restricted from taking any action with respect to any Award if such action would result in a (i) violation of
Section 306 of the Sarbanes-Oxley Act of 2002, and the regulations promulgated thereunder, whether or not such law and regulations are applicable to the Company, or (ii) any policies adopted by the Company restricting transactions in the Stock.

  

	13.3	Stock Restriction Agreement. The Committee may provide that Shares issuable upon the exercise of an Option shall, under certain conditions, be subject to
restrictions whereby the Company has (i) a right of first refusal with respect to such Shares, (ii) specific rights or limitations with respect to the Participant’s ability to vote such Shares, or (iii) a right or obligation to repurchase all
or a portion of such Shares, which restrictions may survive a Participant’s cessation or termination as a Service Provider. 

 SECTION 14 
 OTHER EMPLOYEE BENEFITS 

The amount of any compensation deemed to be received by a Participant as a result of the exercise of an Option or the grant, payment or
vesting of any other Award shall not constitute “earnings” with respect to which any other benefits of such Participant are determined, including benefits under (a) any pension, profit sharing, life insurance or salary continuation plan or
other employee benefit plan of the Company or (b) any agreement between the Company and the Participant, except as such plan or agreement shall otherwise expressly provide. 
 SECTION 15 
 PLAN AMENDMENT, MODIFICATION AND TERMINATION 

 

	15.1	Amendment, Modification, and Termination. The Board may at any time terminate, and from time to time may amend or modify, the Plan; provided, however, that no
amendment or modification may become effective without approval of the amendment or modification by the shareholders if shareholder approval is required to enable the Plan to satisfy any applicable statutory or regulatory requirements, to comply
with the requirements for listing on any exchange where the Shares are listed, or if the Company, on the advice of counsel, determines that shareholder approval is otherwise necessary or desirable. 

  
 26 

	15.2	Adjustment Upon Certain Unusual or Nonrecurring Events. The Board may make adjustments in the terms and conditions of Awards in recognition of unusual or
nonrecurring events (including the events described in Section 4.3) affecting the Company or the financial statements of the Company or of changes in applicable laws, regulations, or accounting principles, whenever the Board determines that such
adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan. 

 

	15.3	Awards Previously Granted. Notwithstanding any other provision of the Plan to the contrary (but subject to a Holder’s employment being terminated for Cause
and Section 15.2), no termination, amendment or modification of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the written consent of the Holder of such Award. 

SECTION 16 

WITHHOLDING 
  

	16.1	Withholding Requirement. The Company’s obligations to deliver Shares upon the exercise of an Option, or upon the vesting of any other Award, shall be
subject to the Participant’s satisfaction of all applicable federal, state and local income and other tax withholding requirements. 

  

	16.2	Withholding with Stock. The Committee may, in its sole discretion, permit the Holder to pay all minimum required amounts of tax withholding, or any part thereof,
by electing to transfer to the Company, or to have the Company withhold from the Shares otherwise issuable to the Holder, Shares having a value not to exceed the minimum amount required to be withheld under federal, state or local law or such lesser
amount as may be elected by the Holder. The Committee may require that any shares transferred to the Company have been held or owned by the Participant for a minimum period of time. All elections shall be subject to the approval or disapproval of
the Committee. The value of Shares to be withheld shall be based on the Fair Market Value of the Stock on the date that the amount of tax to be withheld is to be determined (the “Tax Date”), as determined by the Committee. Any such
elections by Holder to have Shares withheld for this purpose will be subject to the following restrictions: 

  

	 	(a)	All elections must be made prior to the Tax Date; 

  

	 	(b)	All elections shall be irrevocable; and 

  

	 	(c)	If the Participant is an officer or director of the Company within the meaning of Section 16 of the 1934 Act (“Section 16”), the Participant must
satisfy the requirements of such Section 16 and any applicable rules thereunder with respect to the use of Stock to satisfy such tax withholding obligation. 

  
 27 

 SECTION 17 
 NONEXCLUSIVITY OF THE PLAN 
  

	17.1	Nonexclusivity of the Plan. Neither the adoption of the Plan nor the submission of the Plan to shareholders of the Company for approval shall be construed as
creating any limitations on the power or authority of the Board or of the Committee to continue to maintain or adopt such other or additional incentive or other compensation arrangements of whatever nature as the Board or the Committee, as the case
may be, may deem necessary or desirable, or to preclude or limit the continuation of any other plan, practice or arrangement for the payment of compensation or fringe benefits to employees, non- employee directors, non-employee advisory directors or
consultants generally, or to any class or group of employees, non-employee directors, non-employee advisory directors or consultants, which the Company now has lawfully put into effect, including any retirement, pension, savings and stock purchase
plan, insurance, death and disability benefits and executive short-term incentive plans. 

 SECTION 18 

REQUIREMENTS OF LAW 
  

	18.1	Requirements of Law. The issuance of Stock and the payment of cash pursuant to the Plan shall be subject to all applicable laws, rules and regulations, and to
such approvals by any governmental agencies or stock exchanges as may be required. Notwithstanding any provision of the Plan or any Award, Holders shall not be entitled to exercise or receive benefits under any Award, and the Company shall not be
obligated to deliver any Shares or other benefits to a Holder, if such exercise, receipt of benefits or delivery would constitute a violation by the Holder or the Company of any applicable law or regulation. 

 

	18.2	Code Section 409A. This Plan is intended to meet or to be exempt from the requirements of Section 409A of the Code, and shall be administered, construed and
interpreted in a manner that is in accordance with and in furtherance of such intent. Any provision of this Plan that would cause an Award to fail to satisfy Section 409A of the Code or, if applicable, an exemption from the requirements of that
Section, shall be amended (in a manner that as closely as practicable achieves the original intent of this Plan) to comply with Section 409A of the Code or any such exemption on a timely basis, which may be made on a retroactive basis, in accordance
with regulations and other guidance issued under Section 409A of the Code. 

  

	18.3	Rule 16b-3. Each transaction under the Plan is intended to comply with all applicable conditions of Rule 16b-3, to the extent Rule 16b-3 reasonably may be
relevant or applicable to such transaction. To the extent any provision of the Plan or any action by the Committee under the Plan fails to so comply, such provision or action shall, without further action by any person, be deemed to be automatically
amended to the extent necessary to effect compliance with Rule 16b-3; provided, however, that if such provision or action cannot be amended to effect such compliance, such provision or action shall be deemed null and void to the extent permitted by
law and deemed advisable by the Committee. 

  
 28 

	18.4	Governing Law. The Plan and all agreements hereunder shall be construed in accordance with and governed by the laws of the state of Delaware without giving
effect to the principles of the conflict of laws to the contrary. 

 SUBJECT TO THE SHAREHOLDER APPROVAL
REQUIREMENT NOTED BELOW, THIS TVAX BIOMEDICAL, INC. 2011 OMNIBUS EQUITY INCENTIVE PLAN HEREBY IS ADOPTED BY THE BOARD OF DIRECTORS OF TVAX BIOMEDICAL, INC. THIS 22ND DAY OF NOVEMBER, 2011. 

  
 29 

 THE PLAN SHALL BECOME EFFECTIVE ONLY IF APPROVED BY THE SHAREHOLDERS OF THE COMPANY AND
THE EFFECTIVE DATE OF THE PLAN SHALL BE SUCH DATE OF SHAREHOLDER APPROVAL. 
  

			
	TVAX BIOMEDICAL, INC.
		
	By:	 	/s/ Gary W. Wood
		 	Gary W. Wood
		 	President and Chief Executive Officer

  
 30

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]